Smital Shah
Director/Board Member presso PLIANT THERAPEUTICS, INC.
Patrimonio netto: 18 757 $ in data 31/03/2024
Posizioni attive di Smital Shah
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. | Director/Board Member | 14/03/2019 | - |
| Independent Dir/Board Member | 14/03/2019 | - |
Storia della carriera di Smital Shah
Precedenti posizioni note di Smital Shah
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PROQR THERAPEUTICS N.V. | Director of Finance/CFO | 03/10/2014 | 01/10/2022 |
| Investor Relations Contact | 03/10/2014 | - | |
| GILEAD SCIENCES, INC. | Treasurer | 01/08/2012 | 01/09/2014 |
| LENZ THERAPEUTICS, INC. | Director/Board Member | 01/04/2021 | - |
| Independent Dir/Board Member | 01/04/2021 | - |
Formazione di Smital Shah
| Virginia Polytechnic Institute & State University | Graduate Degree |
| University of Mumbai | Undergraduate Degree |
| Haas School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| India | 2 |
| Paesi Bassi | 2 |
Posizioni
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
| Director of Finance/CFO | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| PROQR THERAPEUTICS N.V. | Health Technology |
| PLIANT THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Smital Shah
- Esperienza
